Announcements Trials

Browse Landscape

Phase

Status

Completed 8 Unknown 7 Terminated 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Kidney Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Sorafenib 3 atezolizumab 2 Radiotherapy 2 Bevacizumab 2 tremelimumab 1 temsirolimus 1 lonafarnib 1 liposomal doxorubicin 1 infigratinib 1 gadolinium ethoxybenzyl DTPA 1 fludarabine 1 durvalumab 1 cabozantinib 1 bavituximab 1 aldesleukin 1 Thoracoscopy 1 Thoracic Surgery, Video-Assisted 1 Resveratrol 1 Radiosurgery 1 Radionuclide Generators 1 Radiofrequency Ablation 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 NSC 366140 1 Mass Spectrometry 1 Immunotherapy 1 Immunohistochemistry 1 Genetic Testing 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Liver Neoplasms × Radiofrequency Ablation × Clear all

NCT00510627 2017-03-03

Prometheus

Boston Scientific Corporation

Phase 4 Withdrawn

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡